PIUG 2017 BIOTECHNOLOGY CONFERENCE - BizInt Solutions
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Patent Information Users Group, Inc.
Gaining Competitive Advantage In Biotech Patent Research
Through Constructive Analysis And Client Engagement
PIUG 2017
BIOTECHNOLOGY CONFERENCE
February 27 – 28, 2017 Embassy Suites Boston–Logan Airport Boston, MA
Meeting Book prepared by BizInt Solutions Inc., a proud sponsor of the 2017 PIUG Biotechnology Conference
PIUG 2017 BIOTECHNOLOGY CONFERENCE
February 27 – 28, 2017 Embassy Suites Boston–Logan Airport Boston, MA
C O N F E R E N C E S C H E D U L E : T U E S D AY, F E B R U A R Y 2 8 , 2 0 17
7:00 am – 8:15 am Registration and Breakfast (exhibits open)
8:15 am – 8:25 am Welcome Remarks
8:25 am – 9:10 am Keynote - Global Filing Strategies for the Biotech/Pharmaceutical Patents
Eugene Kim, Ironwood Pharmaceuticals
9:10 am – 9:40 am Quantifying EPO-Style Sequence Listings
Thomas Marman, Pfizer Inc.
9:40 am – 9:50 am Product Reviews – BizInt, GQ Life Sciences
9:50 am – 10:20 am Break & Vendor Exhibits
10:20 am – 10:50 am The Constraint Potential of Biotechnology Patents and Determining
When a Biosimilar Could Enter the Market
Siobhan Palmer, QuintilesIMS
10:50 am – 11:20 am Biosimilars: Trends and Developments in the United States and Europe
David Dunn, Clarivate Analytics
11:20 am – 11:30 am Product Reviews – ProQuest Dialog, Minesoft
11:30 am – 12:00 pm Challenges in Searching Biosimilar Sequences
Julien Doudement, GQ Life Sciences
12:00 pm – 12:10 pm Product Reviews – STN, PatentSight
12:10pm – 1:40 pm Lunch & Vendor Exhibits
1:40 pm – 2:40 pm Open Space Discussion
2:40 pm – 3:10 pm Shining a Light into the Black Box of Patent Examination –
the Nordic Approach
Louise Boisen, Nordic Patent Institute
3:10 pm – 4:00 pm Break & Vendor Exhibits
4:00 pm – 4:30 pm Going beyond the Traditional Patent Search: The Use of Patent Metric
Indicators To Assess Technological Advantage
Greg Roland, Novartis Institute of Biomedical Research
Holger Ernst, WHU- Otto Beisheim School of Management
4:30 pm – 5:00 pm The Role of Text Mining in Patent Research at Boehringer Ingelheim
Thorsten Schweikardt, BI
5:00 pm – 5:30 pm Quality In, Quality Out – Innovation at Minesoft To Help with the “In”!!
Robert Poolman, Minesoft
5:30 pm Closing Remarks
6:30 pm Networking dinner (registration required)
PIUG 2017 Biotechnology Conference Boston, Massachusetts
2017 BIOTECHNOLOGY CONFERENCE
February 27-28, 2017 Embassy Suites Boston-Logan Airport Boston, Massachusetts
TA B L E O F CO N T E N T S
Message from the Chair...............................................................2
Thank You to Sponsors................................................................3
Tuesday Morning Speakers........................................................4
Tuesday Afternoon Speakers.................................................. 16
Sponsor Information.................................................................. 26
Workshops & Hotel Map........................................................... 29
Attendees by Name................................................................... 30
Attendees by Company............................................................ 31
Please complete the evaluation survey for the conference at:
http://www.surveygizmo.com/s3/3346634/PIUG2017Biotech
2 PIUG 2017 Biotechnology Conference Boston, Massachusetts
Welcome
Welcome to the PIUG 2017 Biotechnology Conference!
On behalf of the PIUG Board of Directors, I welcome you to the PIUG 2017 Biotechnology
Conference. The organizing committee has an outstanding program for you. I hope you
learn at least one new thing today. I also hope that you will take advantage of networking
with your colleagues. I find that one of the most profitable aspects of PIUG. We also want
to thank the sponsors of the meeting. Please stop by their booths and hear about their
products and let them know how much we appreciate their support. Welcome to Boston
2017.
Martha Yates, PIUG Chair 2016-2018
The planning committee would like to welcome all attendees to the PIUG 2017
Biotechnology Conference. Now in its 11th year, the conference program has seen an
evolution in the topics from “traditional” sequence searching to concepts such as biosimilars,
text mining, analysis of “big” patent data, sequence listings, filing strategies, and the role of
patent examiners. Our goal is for attendees to leave the conference with new techniques
that they can apply to their daily job, and to connect attendees with vendors who have a
common interest in patent searching.
Please visit the exhibit booths sponsored by BizInt, GQ Life Sciences, Proquest, Minesoft,
STN, and PatentSight to get insights into their unique offerings. PIUG is a membership
supported group always open to new ideas for meeting venues and topics. If you have not
yet joined PIUG, please consider doing so to receive the many benefits of membership.
Thank you for your attendance and supporting PIUG.
The Planning CommitteePIUG 2017 Biotechnology Conference Boston, Massachusetts 3
Platinum Sponsors
gratefully acknowledges BizInt Solutions
the generous support
provided by our sponsors. GQ Life Sciences
The meeting would not exist
without their support!
Silver Sponsors
Minesoft
PatentSight
ProQuest Dialog
STN
Bronze Sponsors
QuintilesIMS4 PIUG 2017 Biotechnology Conference Boston, Massachusetts
MORNING SPEAKERS
Global Filing Strategies for the Biotech/Pharmaceutical Patents
Eugene Kim, Ironwood Pharmaceuticals
8:25– 9:10 am
ABSTRACT
Global filing strategies for protecting biotechnological and pharmaceutical discoveries requires
the careful consideration of a multitude of factors, including cost, overall IP budget, local laws,
market size, enforceability of the patents, to name but a few. In addition, such filings need to be
closely coordinated with ongoing development, clinical, manufacturing and regulatory activities.
In this presentation, I will review these factors in close detail, with particular focus on protecting
therapeutic products and, wherever possible, provide recommendations for companies of different
stages/sizes.
BIOGRAPHY
Gene is Senior Intellectual Property Counsel at Ironwood Pharmaceuticals. He has experience
working at biotech and pharmaceutical companies ranging from early-stage startups to global
pharmaceutical companies, protecting and evaluating IP on a broad range of technologies and
molecules, ranging from biological and small molecule therapeutics, gene and oligonucleotide
therapies, and microbiomes. Prior to joining Ironwood, Gene worked at Pfizer, Indigo Agriculture,
Synageva BioPharma, Alnylam Pharmaceuticals and Biogen. Gene received his Ph.D. in Biology from
the University of Pennsylvania, and his J.D. from the Suffolk University Law School.PIUG 2017 Biotechnology Conference Boston, Massachusetts 5 Global Filing Strategies for the Biotech/Pharmaceutical Patents Eugene Kim, Ironwood Pharmaceuticals
6 PIUG 2017 Biotechnology Conference Boston, Massachusetts
MORNING SPEAKERS
Quantifying EPO-Style Sequence Listings
Thomas Marman, Pfizer Inc.
9:10 – 9:40 am
ABSTRACT
The format of amino acid sequence listings varies between the European Patent Office (EPO)
and the United States Patent & Trademark Office (USPTO). There are distinct differences in the
presentation of alternative or variable amino acids in sequences (e.g., when the residue at a given
position could be alanine or glycine). The EPO requires selection of one of the amino acids in the
group to be represented in the sequence, while other offices, such as the USPTO, require the use of
Xaa to represent these alternative amino acids. This presentation aims to discuss the prevalence of
these EPO-style sequence listings in sequence databases. In order to investigate and quantify these
types of sequences, the annotation/feature tables must be heavily replied upon, since the sequence
alone is not useful in the identification. The majority of the statistics presented here are based on
the freely available sequence data set at EBI-EMBL produced by the EPO. This data set was queried
using Python scripts, which provide more flexibility in the type of queries and fields that can be
searched when compared to most commercial databases.
BIOGRAPHY
Tom is currently in Pfizer’s Patent Searching & Information group and has been a small molecule
patent searcher at both Pfizer and Wyeth for a combined 12 years. Prior experience includes an
additional 4 years searching as a Senior R&D Information Scientist at Dow Chemical after many
years as a bench chemist at ANGUS Chemical, a small specialty chemicals company. He has a Ph.D.
in Organic Chemistry from Texas A&M University and a B.S. in Chemistry from the University of
Connecticut.PIUG 2017 Biotechnology Conference Boston, Massachusetts 7 Quantifying EPO-Style Sequence Listings Thomas Marman, Pfizer Inc.
8 PIUG 2017 Biotechnology Conference Boston, Massachusetts
MORNING SPEAKERS
The Constraint Potential of Biotechnology Patents and
Determining When a Biosimilar Could Enter the Market
Siobhan Palmer, QuintilesIMS
10:20 – 10:50 am
ABSTRACT
Patent thickets around a biologic molecule can make it hard for a patent analyst to determine which
patents are truly protective and prevent the entry of a biosimilar onto the market, and those which
could be circumvented. As many as 20 key patent families could relate to the biologic molecule,
but in reality, a maximum of 5 are likely to be genuine blockers. This challenge is even larger when
considering variability of protection in different geographies. In this session we will explore how
the proprietary constraint analysis of the QuintilesIMS Ark Patent Intelligence database can be used
to compare the expiry dates of these patents, and alongside data/marketing exclusivity, be used
to identify a date at which probable biosimilar entry can be achieved. We will also use examples to
explore strategies which have been employed to protect biologics by Innovators such as Amgen,
who have managed to prolong the protection of Neulasta® (pegfilgrastim) using patents that
protect manufacturing processes rather than the product itself.
BIOGRAPHY
Siobhán Palmer has a BSc in Chemistry from the University of Surrey. Siobhan joined QuintilesIMS,
previously IMS Health, 8 years ago as a patent analyst for IMS Health’s Patent Focus database.
Siobhan’s current role is as Product Manager for the Ark Patent Intelligence database.PIUG 2017 Biotechnology Conference Boston, Massachusetts 9 The Constraint Potential of Biotechnology Patents and Determining When a Biosimilar Could Enter the Market Siobhan Palmer, QuintilesIMS
10 PIUG 2017 Biotechnology Conference Boston, Massachusetts
MORNING SPEAKERS
Biosimilars: Trends and Developments in the United States
and Europe
David Dunn, Clarivate Analytics
10:50 – 11:20 am
ABSTRACT
Biosimilars are an emerging competitive force within the biopharmaceuticals industry. Blockbuster
biologics have lost patent and market exclusivity in major markets including the US and Europe. Major
firms such as Sandoz, Amgen and Hospira (Pfizer) have launched biosimilars in Europe and the US and they
have more products in the late stages of development and approval. Thomson Reuters will review the
current pipeline of biosimilars and how they directly or indirectly threaten branded products. We will look
at the challenges of bringing these products to market and how innovators and biosimilars developers are
applying strategies to influence the landscape in their favor.
BIOGRAPHY
David Dunn is US Practice Lead and Scientific Advisor in the Portfolio and Licensing Services group at
Clarivate Analytics. He has over 20 years of experience in the pharmaceutical industry and advises clients
on management and optimization of their research and commercial portfolios.PIUG 2017 Biotechnology Conference Boston, Massachusetts 11 Biosimilars: Trends and Developments in the United States and Europe David Dunn, Clarivate Analytics
12 PIUG 2017 Biotechnology Conference Boston, Massachusetts
MORNING SPEAKERS
Challenges in Searching Biosimilar Sequences
Julien Doudement, GQ Life Sciences
11:30 am – 12:00 pm
ABSTRACT
Biosimilar monoclonal antibodies present many challenges for information retrieval. What does
similar really mean and what are the consequences when searching patents? Examples of recent
biosimilars on the market will be reviewed to highlight the oncoming obstacles for researchers and
patent searchers.
BIOGRAPHY
Julien Doudement is a Product Manager at GQ Life Sciences. He advises customers on patent search
best practices, while advancing new product features and content delivery. With 10 years at the
company, he combines extensive biological research experience with a deep understanding of
the GQ platform. Previously at Servier Laboratories, he immersed himself in the daily application
of information technology to biological problems in drug discovery. He holds Master Degrees in
Biology and Bioinformatics.PIUG 2017 Biotechnology Conference Boston, Massachusetts 13 Challenges in Searching Biosimilar Sequences Julien Doudement, GQ Life Sciences
14 PIUG 2017 Biotechnology Conference Boston, Massachusetts
RE-INVENT THE USER EXPERIENCE
APPLY TODAY AND RECEIVE
BETA ACCESS!
contact us: +1 844-841-3059 or visit gqlifesciences.comPIUG 2017 Biotechnology Conference Boston, Massachusetts 15
GQ-PAT GROWTH
LAST
2
YEARS16 PIUG 2017 Biotechnology Conference Boston, Massachusetts
AFTERNOON SPEAKERS
Open Space Discussion
1:40 – 2:40 pm
PROPOSED TOPICS:
»» Searcher Certification
»» Co-occurring Biotech + Northeast meeting
»» New tools or Road-maps from Vendors
»» Suggestions and feedback for search products
»» Current challenges and trends in biotech searching, for example:
»» target searches
»» diagnostics
»» devices
»» wearable devices
»» The role of patent competitive intelligence
»» Other suggestions from audiencePIUG 2017 Biotechnology Conference Boston, Massachusetts 17 Open Space Discussion
18 PIUG 2017 Biotechnology Conference Boston, Massachusetts
AFTERNOON SPEAKERS
Shining a Light into the Black Box of Patent Examination –
the Nordic Approach
Louise Boisen, Nordic Patent Institute
2:40 – 3:10 pm
ABSTRACT
Gain an insight into practical patent examination and the thought processes of an examiner and use
this insight when evaluating the relevance of prior art in your own searches. In this presentation you will
be introduced to the daily life of an examiner from the Nordic Patent Institute (NPI). I will illustrate how
the examiners at NPI work and, in particular, how we think when considering novelty and obviousness.
A key part of the process involves a dialogue between applicant and examiner prior to search. The
dialogue serves to accurately determine the essence of the invention and identify fallback positions
not necessarily apparent from the initial claims. Tailoring the search accordingly, the examiner can thus
provide the applicant with the information necessary for adapting the application for further progress
around the world.
BIOGRAPHY
Louise Boisen has worked as a patent examiner at the Nordic Patent Institute (NPI) and the Danish
Patent and Trademark Office (DKPTO) since January 2014. Apart from searching and examining
national and PCT patent applications, she also delivers IP services to businesses throughout the world.
In addition, Louise is responsible for implementing best practice procedures and developing new
services for the commercial search service units of both NPI and DKPTO. Louise has a background in
recombinant antibody technology with a Ph.D. from the University of Aarhus, Denmark, and did her
postdoctoral training at Warwick Medical School, Coventry, UK.PIUG 2017 Biotechnology Conference Boston, Massachusetts 19 Shining a Light into the Black Box of Patent Examination – the Nordic Approach Louise Boisen, Nordic Patent Institute
20 PIUG 2017 Biotechnology Conference Boston, Massachusetts
AFTERNOON SPEAKERS
Going beyond the Traditional Patent Search –
The Use of Patent Metric Indicators To Assess Technological
Advantage
Greg Roland, Novartis Institute of Biomedical Research
and Holger Ernst, WHU – Otto Beisheim School of Management
4:00 – 4:30 pm
ABSTRACT
The traditional patent search for determining FTO or patentability involves the use of multiple
resources to take advantage of value-added indexing or searcher developed free-text strategy. Once
a set of references has been identified, the results are typically summarized to bring to the attention
of the practitioner relevant aspects of the identified references as they pertain the query. The
searcher is often asked to rank results by relevance, date, number of family members or those with
dominating claims. This is a subjective exercise representing a snapshot in time but does not display
trends or allows for a comprehensive view with a reliable and objective method. New methods
to review patent search results are now available as a way to assess the competitive advantage of
assignee’s portfolio. Early efforts to establish rankings were based on quantitative or qualitative
assessments that lacked global coverage or relied on statistical correlations to patent maintenance
rates. The use of empirical indicators such as Market Coverage™, Technology Relevance™,
Competitive Impact™ and the Patent Asset Index™ can establish a reliable and objective numerical
value of an individual patent family or an organization’s entire portfolio. In this presentation these
empirical indicators developed by PatentSight will be used to analyse the clustered regularly
interspaced short palindromic repeats (CRISPR) area, a method to edit or delete existing genes,
as a method to assess the technological position of an organization, its innovativeness as well as
sustainable competitive advantage.
BIOGRAPHIES
Holger Ernst is full professor of business administration, esp. technology and innovation
management at the WHU - Otto Beisheim School of Management, Vallendar, Germany. Prof. Ernst’s
research interests lie in the fields of strategy, innovation, commercialization of technologies, new
product development and intellectual property. Prof. Ernst is co-founder of PatentSight, located in
Bonn, Germany, that specializes in the development and selling of software products and consulting
services in the field of business intelligence based on patent data.
Greg Roland is currently the Global Head of Search and Analytics within the patent department at
the Novartis Institutes of BioMedical Research (NIBR) located in Cambridge, MA. Greg has 26 years
of experience in the pharmaceutical industry and searching the patent literature and competitor
pipeline databases.PIUG 2017 Biotechnology Conference Boston, Massachusetts 21 Going beyond the Traditional Patent Search: The Use of Patent Metric Indicators To Assess Technological Advantage Greg Roland, Novartis Institute of Biomedical Research and Holger Ernst, WHU – Otto Beisheim School of Management
22 PIUG 2017 Biotechnology Conference Boston, Massachusetts
AFTERNOON SPEAKERS
The Role of Text Mining in Patent Research at Boehringer
Ingelheim
Thorsten Schweikardt, BI
4:30 – 5:00 pm
ABSTRACT
Scientists can spend a lot of their time separating patents relevant to a specific question from
non-significant ones. We have developed a patent analysis workflow to prioritize the patents
being reviewed in order to save the scientist’s time and cut costs by using text mining and other
techniques. We will explain that process and the benefits derived from it. The optimal prioritization
criteria can be defined freely for each project, making the workflow very flexible to use. We describe
the general workflow using text mining and pipelining tools like Linguamatics I2E and KNIME, and
take a look at challenges and possible future enhancements.
BIOGRAPHY
Thorsten is a Senior Information Scientist at the Scientific Information Center of Boehringer
Ingelheim Pharma located in Biberach, Germany. He provides project support for early-to-late stage
projects in RD&M with database research, information retrieval and text mining. He is a structural
biologist by training and holds a Ph.D. from the University of Mainz, Germany.PIUG 2017 Biotechnology Conference Boston, Massachusetts 23 The Role of Text Mining in Patent Research at Boehringer Ingelheim Thorsten Schweikardt, BI
24 PIUG 2017 Biotechnology Conference Boston, Massachusetts
AFTERNOON SPEAKERS
Quality In, Quality Out –
Innovation at Minesoft To Help with the “In”!!
Robert Poolman, Minesoft
5:00 – 5:30 pm
ABSTRACT
The quality of any search stems from the comprehensiveness of a search strategy. Although no
database can do the search for you, it can provide features and functionality to help. Delivered from
the perspective of an experienced biotech patent analyst, we will use case studies to discuss the
challenges in ensuring comprehensiveness and the features and functionality of PatBase which can
help, including: (1) PatBase Thesaurus to help identify synonyms, acronyms, names and numbers
(2) PatBase Semantic searching to broaden any patent search (3) Non-patent literature searching in
PatBase to identify relevant prior art (4) The ability to link to relevant information including sequence
information, clinical trial data and FDA OrangeBook information. This presentation will demonstrate
how any user can benefit from the innovative features and functionality in PatBase to craft a
meaningful patent analysis.
BIOGRAPHY
Rob is currently a Senior Manager (Innovation and Consulting) at Minesoft Ltd, UK. In 2000, and
having completed a Ph.D. in Biochemistry, Rob started his career at Pfizer as a Biotechnology
Information Consultant providing biomedical, patent and competitive intelligence to both research
scientists and patent attorneys. During 6 years at Pfizer, he helped form and lead a high-performing
team of information professionals within the Legal division. In 2006, he joined Novartis to create and
manage the NIBR Search and Analytics team and during the last 3 years at Novartis, Rob completed
an M.B.A. at Warwick Business School which allowed him to take on additional operational and
managerial responsibilities. With over 15 years of experience in the information industry, Rob
has recently joined Minesoft to spearhead their future product development, to enhance their
consultancy based approach and to bring an end user perspective to the company.PIUG 2017 Biotechnology Conference Boston, Massachusetts 25 Quality In, Quality Out – Innovation at Minesoft To Help with the “In”!! Robert Poolman, Minesoft
26 PIUG 2017 Biotechnology Conference Boston, Massachusetts
Platinum Sponsors
BIZINT SOLUTIONS, INC.
BizInt Smart Charts software helps information analysts create, customize and distribute competitive intelligence
reports and visualizations from drug pipeline, clinical trial, patent and gene sequence databases. The BizInt Smart
Charts product family is used by pharmaceutical, biotech, chemical and device/diagnostics companies worldwide to
support product lifecycle planning and portfolio management.
GQ LIFE SCIENCES
GQ Life Sciences an Aptean company enables life science companies to search worldwide patent literature for
DNA and other biological sequences. Its database, GQ-Pat, is the largest repository of such patented sequences. IP
professionals and law firms use GenomeQuest to perform freedom to operate, patentability, and prior art searches.
GenomeQuest serves 18 of the top 20 pharmaceutical companies and all five top agrochemical companies, with a
customer base of nearly 200 leading life sciences organizations.PIUG 2017 Biotechnology Conference Boston, Massachusetts 27
chemical explorer
Extract essential chemical information
from full textpatents with Chemical Explorer
• Perform a chemical structure search against FULL TEXT
• Instantly retrieve compounds occurring throughout the document
• Patent documents publishing in English language, German, French,
Japanese, Chinese and Korean
Chemical Explorer, TextMine and PatBase: a unique, powerful combination
to instantly identify and review the exact location of the chemical
compound in the full text of patent documents as never before
www.minesoft.com/chemical-structure-searching
AN ANALYTICS PLATFORM CREATED FOR
STRATEGIC IP MANAGEMENT
R&D STRATEGY PatentSight offers an unparalleled patent
BENCHMARKING analytics platform enabling you to take the
quality of patents into account using the
Patent Asset Index™.
TRENDS 6 of the top 10 chemical companies in the
PORTFOLIO world use PatentSight for their IP strategy
MGMT development and portfolio management
needs.
M&A LICENSING A PLATFORM BUILT TO DRIVE DECISIVE
ACTION
WWW.PATENTSIGHT.COM28 PIUG 2017 Biotechnology Conference Boston, Massachusetts
PRECISE SEARCHING
FOR PROFESSIONALS
CONTENT.
POWER.
RELIABILITY.
When it comes to searching, trust the experts. STN is the most complete search and retrieval platform for the
world’s disclosed scientific and technical research. Only STN offers CAS REGISTRYSM and other authoritative
databases, Thomson Reuters’ Derwent World Patents Index®, and the most complete offering of science and
technical content along with unparalleled search precision. The world’s patent offices rely on STN, shouldn’t you?
For more information, visit the STN booth today! www.stn.orgPIUG 2017 Biotechnology Conference Boston, Massachusetts 29
CONFERENCE WORKSHOPS
Monday, Feb 27 Workshop
10:00 am – 12:00 pm PIUG-Sponsored Presentation
Searching Biotechnological Inventions under the EPC
Dr. Klaus-Peter Dopfer, EPO
1:00 pm – 2:00 pm Creating IP Sequence Reports with BizInt Smart Charts:
Tips & Tricks
John Willmore
2:30 pm – 3:30 pm GQ Life Sciences: Updates
Julien Doudement
4:00 pm – 5:00 pm Minesoft: The Latest Solutions From Minesoft
Rob Poolman30 PIUG 2017 Biotechnology Conference Boston, Massachusetts
AT T E N D E E S BY N A M E
Baldwin, Christopher............................PatentSight Trippe, Anthony......................................Patinformatics
Barrett, Dianah.........................................Pfizer Turner, Elyse..............................................
Boisen, Louise..........................................Nordic Patent Institute Tzimas, Maritsa........................................GlaxoSmithKline
Brown, Jim.................................................FIZ Karlsruhe Weiss-Nolen, Monica............................Sanofi
Butler, Barbara..........................................Sanofi Willmore, John.........................................BizInt Solutions
Cawley, Dillon...........................................Abbott Wu, Danyu.................................................GQ Life Sciences
Chiu, George.............................................Johnson & Johnson Yates, Martha............................................Monsanto Company
Danko, Anthony......................................ProQuest Yuan, Qiong..............................................CAS
De Greef, Sarah........................................darts-ip
Doepfer, Klaus-Peter.............................European Patent Office
Doudement, Julien................................GQ Life Sciences
Dunn, David..............................................Clarivate Analytics
Eberle, Matt...............................................BizInt Solutions
Eichelman, Cynthia................................Linguamatics
Ernst, Holger.............................................PatentSight
Faerman, Carlos.......................................Independent
Fisher, Donna............................................IPSEN Bioscience
Gore Willse, Ann.....................................Boehringer Ingelheim
Hampton, Barbara.................................RedLine Information Services
Humel Denton, Alice............................CAS
Jiang, Ning.................................................Pfizer
Kim, Eugene..............................................Ironwood Pharmaceuticals
Kocis, Helena............................................
Kratunis, John...........................................CAS
LeBeau, Susan..........................................Linguamatics
Leung, Benjamin.....................................Global Prior Art
Lim, Jimmy................................................Panasonic Corporation
Marman, Thomas...................................Pfizer
Mendelson, Seth.....................................Eisai
Meng, Qin..................................................Bright Information Group
Miller, Nicholas.........................................ipan
Miller, Barbara..........................................Novartis
Ostanock, Phillip.....................................Minesoft
Palmer, Siobhan......................................QuintilesIMS
Patankar, Gargee.....................................Gridlogics Technologies
Perkins, Bill.................................................GQ Life Sciences
Poolman, Robert....................................Minesoft
Reeve, Mary Jane....................................GlaxoSmithKline
Robins, Suzanne.....................................Patent Information Services
Roland, Greg.............................................Novartis
Ropke, Ken.................................................Minesoft
Sandvoss, Leah........................................Pfizer
Schweikardt, Thorsten.........................Boehringer Ingelheim
Shanker, Sumana....................................Shire Pharmaceuticals
Taylor, Alison.............................................AbbottPIUG 2017 Biotechnology Conference Boston, Massachusetts 31 AT T E N D E E S BY CO M PA N Y Abbott.........................................................Dillon Cawley ProQuest.....................................................Anthony Danko Abbott.........................................................Alison Taylor QuintilesIMS..............................................Siobhan Palmer BizInt Solutions........................................Matt Eberle RedLine Information Services..........Barbara Hampton BizInt Solutions........................................John Willmore Sanofi...........................................................Barbara Butler Boehringer Ingelheim..........................Ann Gore Willse Sanofi...........................................................Monica Weiss-Nolen Boehringer Ingelheim..........................Thorsten Schweikardt Shire Pharmaceuticals..........................Sumana Shanker Bright Information Group...................Qin Meng CAS................................................................Alice Humel Denton CAS................................................................John Kratunis CAS................................................................Qiong Yuan Clarivate Analytics..................................David Dunn darts-ip........................................................Sarah De Greef Eisai...............................................................Seth Mendelson European Patent Office.......................Klaus-Peter Doepfer FIZ Karlsruhe.............................................Jim Brown GlaxoSmithKline.....................................Mary Jane Reeve GlaxoSmithKline.....................................Maritsa Tzimas Global Prior Art........................................Benjamin Leung GQ Life Sciences.....................................Julien Doudement GQ Life Sciences.....................................Bill Perkins GQ Life Sciences.....................................Danyu Wu Gridlogics Technologies.....................Gargee Patankar Independent............................................Carlos Faerman ipan...............................................................Nicholas Miller IPSEN Bioscience.....................................Donna Fisher Ironwood Pharmaceuticals...............Eugene Kim Johnson & Johnson..............................George Chiu Linguamatics............................................Cynthia Eichelman Linguamatics............................................Susan LeBeau Minesoft.....................................................Phillip Ostanock Minesoft.....................................................Robert Poolman Minesoft.....................................................Ken Ropke Monsanto Company.............................Martha Yates Nordic Patent Institute.........................Louise Boisen Novartis.......................................................Barbara Miller Novartis.......................................................Greg Roland Panasonic Corporation........................Jimmy Lim Patent Information Services..............Suzanne Robins PatentSight ...............................................Christopher Baldwin PatentSight ...............................................Holger Ernst Patinformatics..........................................Anthony Trippe Pfizer.............................................................Dianah Barrett Pfizer.............................................................Ning Jiang Pfizer.............................................................Thomas Marman Pfizer.............................................................Leah Sandvoss
32 PIUG 2017 Biotechnology Conference Boston, Massachusetts
PATENT INFORMATION USERS GROUP, INC.
The International Society for Patent Information Professionals
The Patent Information Users Group, Inc. (PIUG) – The International Society for Patent Information Professionals
is a not-for-profit organization for individuals having a professional, scientific or technical interest in patent
information. The mission of PIUG is to support, assist, improve and enhance the success of patent information
professionals through leadership, education, communication, advocacy and networking. Through this
international forum and discussion, we also promote and improve the retrieval, analysis and dissemination of
patent information.
PIUG has over 500 active members representing 24 countries including the United States. The largest
concentration of members is from the USA, Europe and India. PIUG members are patent attorneys, patent
agents, licensing professionals, patent information researchers, patent information vendors, and patent
information and documentation experts from the U.S. and abroad.
We have nearly 300 patent information professionals who do patent searching for corporations, over 100 patent
information consultants, over 80 patent information professionals who do patent searching for law firms, and
about 12 searchers based in academic institutions. We are employed in performing patentability, freedom-to-
practice, and validity patent searches for Fortune 500 / multinational companies, leading universities and major
IP law firms. In recent years, PIUG members have also engaged in patent information analysis as a strategic
innovation tool.
PIUG has an active Discussion Forum that is featured on the PIUG wiki, a global collaborative tool with over 1800
subscribers worldwide. In addition, we have presence in professional and social networking channels, such as
LinkedIn and Twitter. Get to know us and meet the PIUG Officers.
BRIEF HISTORY
The Patent Information Users Group (PIUG) was established in 1988. The objective of the group was to create
a forum to discuss issues and concerns relevant to the patent searcher community. PIUG promotes the
importance of intellectual property, especially patent publications, and most specifically, the computerized
patent databases. Since 1988, PIUG has worked with intellectual property database producers and vendors to
maintain and to improve the quality of their product from the customer, or user, perspective. Please see the
PIUG History page for much more information about PIUG.
MEMBERSHIP INFORMATION
Membership is based on the calendar year. Renewals after October 1 are effective until December 31 of the
following year. The one-year membership fee is $95 (US). The discounted annual membership fee is $50 (US)
and is available for full-time students, full-time retirees, individuals unemployed at the time of renewal, and
individuals residing in an emerging country as defined by PIUG as low, lower middle or upper middle income
countries on the World Bank’s World Bank List of Economies spreadsheet.
For a list of membership benefits please visit our website: www.piug.org/membershipSAVE THESE DATES!
PIUG 2017
ANNUAL CONFERENCE
The Complete 21 st Century Patent Searcher –
Addressing Our Skills Gap
MAY 20 - 25 KEYNOTE SPEAKER
NICHOLAS BELKIN
Crowne Plaza Atlanta Perimeter Distinguished Professor of Information Science,
at Ravinia, Atlanta, GA Department of Library & Information Science,
School of Communication & Information, Rutgers University
PIUG 2017 UPCOMING PIUG COURSE
Patent Searching Fundamentals
NORTHEAST CONFERENCE
MARCH 22–23, 2017
SEPTEMBER 25 – 27 Global Intellectual Property Academy (GIPA),
USPTO, Alexandria, VA
APA Hotel Woodbridge, Iselin, NJ
ATTENDEE COMMENTS FROM A PREVIOUS PIUG CONFERENCE:
“It is a great opportunity to talk with peers, get
“Excellent…speakers from variety of
new ideas and be reminded of the essentials.
industry and background”
I thoroughly enjoy the conference.”
“Timely training on current TECHNIQUES and TOOLS”
“My first PIUG annual meeting and overall it was a great experience. As a first
“PIUG has certainly helped time attendee and speaker, I was initially intimidated, but so many of the “regulars”
me a great deal in search were open and welcoming, it was actually less stressful than I expected. The
and analysis for my projects” first timer’s meeting was a blast, due in part to the great volunteers. I’m looking
forward to attending next year now that I know better what to expect.”
KEY MEMBER BENEFITS
• PIUG Membership Directory (Members-Only Site) • Quarterly e-Newsletter & Access to Archives
• Members-only access to Conference Proceedings • Enhanced functionality on PIUG Wiki
(Annual, Biotech, and Northeast Conferences) • Ongoing professional training through conferences and
• Access to PIUG Salary Surveys workshops
• Discounts for World Patent Information, Pharmaceutical Patent • Access to PIUG LinkedIn group
Analyst & JSTOR
Patent Information Users Group, Inc. • 40 E.Main Street, #1438 • Newark,DE 19711
Phone: (302) 660-3275 • Email: PIUGinfo@piug.org • www.piug.orgAre you using
the best tools
and ingredients?
• Integrate timely data
and unique content
from each source.
• Quickly create reports
combining sequence
and IP data.
• Select and summarize
data based on your
database rankings and
rules.
• New in Version 4: support for new STN;
new fields in PatBase, Orbit, GenomeQuest;
new Summary Record export.
Come talk with us in the Exhibit Hall.
Contact us at support@bizint.com for a demonstration or free trial.
SE
ATTLE
We’ve moved!
We’ve relocated our office to
N
the beautiful state of Washington
WA
SH
INGT
O
in the Pacific Northwest.
www.bizint.comYou can also read
